Skip to content

Establishment and Clinical Application of a Stroke Recurrence Risk Assessment Model for Patients with Atrial Fibrillation Complicated by Cerebral Infarction

Establishment and Clinical Application of a Stroke Recurrence Risk Assessment Model for Patients with Atrial Fibrillation Complicated by Cerebral Infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108100
Enrollment
Unknown
Registered
2025-08-25
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation and Cerebral Infarction

Interventions

Atrial Fibrillation with Cerebral Infarction Group:None

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Patients meet the diagnostic criteria for cerebral infarction established by the 2013 American College of Cardiology/American Stroke Association and the diagnostic criteria for atrial fibrillation established by the 2014 American College of Cardiology; 2.Patients have a history of non-valvular atrial fibrillation and have experienced a first-ever spontaneous cerebral infarction or transient ischemic attack (TIA); 3. Patients are admitted to the study center for treatment within 7 days of symptom onset; 4.Patients are over 18 years of age and voluntarily sign an informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Severe coagulation disorders or hepatic and renal insufficiency (creatinine clearance rate 3); 4. Poor compliance that would prevent completion of follow-up.

Design outcomes

Primary

MeasureTime frame
The rate of stroke recurrence within 3 years;Type of stroke recurrence;Independent risk factors;

Secondary

MeasureTime frame
Peripheral vascular events;Major bleeding events;All-cause mortality rate;Functional score changes;Anticoagulant treatment adherence;

Countries

China

Contacts

Public ContactLi Chen

The First Affiliated Hospital of Guangxi Medical University

chenli@gxmu.edu.cn+86 136 6960 8734

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026